ClinicalTrials.Veeva

Menu

Multiple Sclerosis and Heavy Progressive Resistance Training

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Multiple Sclerosis

Treatments

Behavioral: Resistance training

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the present investigation is to determine whether MS patients can tolerate and benefit from heavy progressive resistance training. A second purpose is to determine both neural and muscle morphological adaptations to heavy progressive resistance training.

Full description

Multiple sclerosis (MS) patients are characterized by reduced muscle strength and functional capacity. For MS patients, improvements in muscle strength and thereby functional capacity, would have the potential to make both the daily living easier and to extend the time living independently. Attempts to improve muscle strength and function include the application of physical training, although the general advice to MS patients for many years has been to avoid participation in physical training. It has now been demonstrated that endurance training at low to moderate intensity is well tolerated by MS patients, but it only induces modest improvements in both muscle strength and functional capacity. Heavy progressive resistance training (HPRT) has proven to be the most effective means to improve muscle strength and functional capacity during daily activities in healthy older people. However, the effects of HPRT have not been investigated in randomised control trials in MS patients.

Enrollment

36 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Relapsing Remitting Multiple Sclerosis according to the McDonald criteria
  • Expanded Disability Status Scale Score between 3,0-5,5
  • Be able to walk at least 100m
  • Be able to train twice a week at the University

Exclusion criteria

  • Alcohol abuse, Alzheimer's and pacemaker
  • Comorbidities like cardiovascular-, respiratory-, orthopaedic or metabolic diseases
  • Having had an attack in a period of 8 weeks prior to the start of the intervention period
  • Having an attack during the intervention period
  • Pregnancy
  • Systematic resistance training in a period of 3 months prior to the start of the intervention period.
  • Training adherence of less than 85%.

Trial design

36 participants in 1 patient group

A
Experimental group
Description:
12 weeks of resistance training
Treatment:
Behavioral: Resistance training

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems